Valuation: Net Medical Xpress Solutions Inc

Market Cap 1.07M 941K 873K 803K 1.51M 104M 1.53M 10.4M 4.07M 50.69M 4.03M 3.94M 175M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 724K 672K 618K 1.16M 79.77M 1.18M 8.01M 3.14M 39.03M 3.1M 3.04M 135M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
Manager TitleAgeSince
President - 25/06/2019
Director TitleAgeSince
Director/Board Member 64 31/12/2002
Director/Board Member 84 31/12/2004
Director/Board Member - 28/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.86%-1.34%-22.75%+13.55% 2,955B
-6.10%-6.87%-16.44%+658.19% 318B
-2.96%-2.78%+228.64%+1,042.13% 125B
-2.21%-9.28%+5.45%+38.77% 95.06B
-3.54%-7.07%+69.63%+123.69% 90.7B
-2.95%-11.21%-38.61%-16.83% 74.5B
-1.30%-5.82%-32.26%+71.43% 65.08B
-1.00%-4.19%+1.09%+55.76% 43.8B
-5.45%-13.02%-58.70%+22.36% 37.59B
Average -2.07%-3.14%+15.12%+223.23% 422.74B
Weighted average by Cap. -0.48%+1.92%-11.59%+105.52%

Financials

2015 2016
Net sales 4.22M 3.7M 3.43M 3.16M 5.95M 407M 6.03M 40.91M 16.01M 199M 15.85M 15.51M 689M 3.04M 2.67M 2.48M 2.28M 4.29M 294M 4.35M 29.51M 11.55M 144M 11.43M 11.18M 497M
Net income 151K 132K 123K 113K 213K 14.57M 216K 1.46M 573K 7.13M 567K 555K 24.63M -344K -301K -280K -257K -485K -33.19M -492K -3.33M -1.3M -16.24M -1.29M -1.26M -56.11M
Net Debt -340K -298K -277K -254K -479K -32.81M -486K -3.29M -1.29M -16.05M -1.28M -1.25M -55.46M -247K -216K -201K -185K -348K -23.83M -353K -2.39M -937K -11.66M -927K -907K -40.29M
Logo Net Medical Xpress Solutions Inc
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
-